Menu

Reinsurance News

Allianz, MS&AD in mix to buy Aviva’s Asian operations, reports

24th September 2019 - Author: Charlie Wood

Reports have emerged from Reuters claiming that Allianz, Nippon Life and MS&AD are among a dozen companies are actively looking to purchase the Asian operations of UK insurer Aviva.

AvivaAviva confirmed earlier this year that it was examining options for a sale of the business as part of a new strategy designed to revitalise the company.

While the insurer’s shares have not fared well over the last 12 months, it is hoped the appointment of new CEO Maurice Tulloch in March will help facilitate a turnaround.

Now, Reuters sources claim that Aviva’s Asian operations could be worth up to $2.5 billion and that last week was the deadline for the first round of formal bids. It’s believed Aviva wants to wrap up a deal by the end of this year.

Furthermore, because Aviva was not combining its other smaller Asian businesses in this sale, interest in the two assets was strong and buyers could end up paying more than $2.5 billion.

It had previously been reported that HSBC was in the early stages of weighing an offer for at least part of Aviva’s Asian business, as part of a push for further business diversification in the region.

Reuters adds that Aviva, Allianz, Nippon Life, MS&AD and Sun Life declined to comment.

Print Friendly, PDF & Email

Recent Reinsurance News

Getting your daily reinsurance news from Reinsurance News is a simple way to receive only the reinsurance industry news that matters, delivered directly to your email inbox.

  • Only email is mandatory, but the more you tell us about yourself the better we can serve you in future!
  • This field is for validation purposes and should be left unchanged.

By submitting the form you are giving your consent to be emailed by us.

Read previous post:
Lloyd’s announces new parametric solution targeting hotel profit protection

The specialist Lloyd's of London insurance and reinsurance marketplace has announced the launch of the first policy developed by Lloyd's...

Close